Deep dive · NMS: CRNX
Crinetics Pharmaceuticals Inc stock analysis
Everything behind the call on Crinetics Pharmaceuticals Inc. 6 sections, ordered the way risk stacks up: survival first, quality and price in the middle, context last. The Beacon gives you the read. This is where you check the work.
The five reads
Why the reads disagreeread this before the sections
Event and Street are pulling against each other and one side is clearly ahead. The net lands at -7 over 30d, a moderate reading on a dispersion of 0.16.
Leans up · and why
earnings vote up. 1 of 5 independent evidence families agree.
Leans down · and why
analyst moves, quality / value, insider flow vote down. 4 of 5 families lean the other way. The conflict that matters is Event against Street.
What it changes
Size, not direction. dealers are long gamma, so their hedging absorbs moves rather than amplifying them.
Global tape
No overseas listings — CRNX trades on its home exchange only.
The bottom linestart here
Wall Street rating
Buy
Across 14 covering firms
11% buy · 89% hold · 0% sell
Earnings
In 38 days
5 Nov 2026 · options imply ±0.0%
beat 3–4 of the last 8
cohort P(beat) 53% · n=38,466
cohort P(beat) 53% · n=38,466
Valuation
-21.2× forward
Against consensus earnings
FCF yield -4.26%
Dividend
0.00%
A rounding error against cash — this is a capital-gains position
Risk flags
1 critical
5 checks run, 2 clear
worst drawdown 0%
New to this? Every metric carries a plain-English read beside it, and an ⓘ next to a label opens the definition. Anything unfamiliar is also defined at the foot of the page under Glossary.
In one paragraphwhat the company actually does214 chars
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
NMS · USDBiotechnology
$84.950.00 · 0.00%CLOSED · vol 8.18M
52-week range↑ 163% off low · ↓ 0.1% off high
$32.30now $84.95$85.01
Quote Aug 31, 2026 · 4:00 PM ET
Tape 2026-09-02
Tape 2026-09-02
01Ratios · Jul 7, 2026SOLVENT · 1 FLAGGED
Survival & solvency
Altman-Z of 16.0 against a 3.0 safe threshold, and 2 of 5 forensic checks clear.
↳ Plain EnglishBefore anything else: can this company pay its bills? These blocks check the balance sheet, whether your slice of ownership is being diluted, and whether the accounting looks honest.
Bankruptcy risk (Altman-Z)
16.00SAFE ZONE
Distress<1.8
Grey1.8–3.0
Safe>3.0
Profitability, leverage and liquidity combined into one number. Above 3.0 is the safe band.
Balance sheetJul 7, 2026
Distance to default (Merton)COMFORTABLE
10.7σ
How many standard deviations of asset value sit between the company and its debt. Above 4σ is comfortable.
1-year default probabilityEDF-CALIBRATED
0.100%
Calibrated against how often companies at this distance actually defaulted, rather than assuming a normal distribution.
Piotroski F-scoreCRITICAL
F 2/9
Piotroski F-score 2 of 9. Nine pass/fail tests covering profitability, leverage and operating efficiency; seven or more is strong.
Solvency and liquidity ratios
Current ratioshort-term assets against short-term bills12.32×healthy >2
Debt / equityborrowings against shareholder capital0.05
Net cashcash on hand in excess of every borrowing$52.99M
Your ownership stake
Share-count growth vs peersHIGH DILUTION
94th pctile
Where this name's share-count growth ranks among peers. Lower is less dilutive.
Stock-based comp / revenueELEVATED
1,182.7%
Stock comp is the dilution pressure a buyback has to outrun. We read up to 5% of revenue as modest and above 12% as heavy — our own reading band, not a measured peer statistic.
Diluted vs basic share gapTHIN OVERHANG
0.00%
Options and awards already granted, expressed as the gap between the diluted and basic counts.
Accounting forensicsSEC filings
Red-flag x-rayGRADE C
62 / 100
1 critical · 1 watch · 2 clear of 4 scored tests
Red-flag x-ray · every check, passes included
CheckStatusValueWhat it looks for
Bankruptcy distressCLEARZ 16.00Altman-Z in the Safe · fundamentals
Earnings manipulationNAn/aBeneish-M not available · fundamentals
LeverageCLEARLTD/E 0.04long-term debt 0.04× equity · fundamentals
Profitability qualityCRITICALF 2/9Piotroski F-score 2 of 9 · fundamentals
Filing forensicsWATCH1 flag1 filing red flag on the latest 10-K · forensic
5 checks, 2 clear and 1 watch and 1 critical. The passes are shown because a score built from five checks means something different from one built from three.
02Refreshed · Sep 28, 2026FAIR · 44/100
Business quality
-6,046% net margin, -47% return on equity, +641% revenue growth, and capital earning -40% against a 8% cost.
↳ Plain EnglishMargins tell you how much of each sales dollar the company keeps. Return on capital tells you whether reinvesting that money creates value. Both are read against what the filings support, not against a target.
Quality score
44 / 100FAIR
Profitability, growth and balance strength scored separately, then blended.
ProfitabilityRefreshed · Sep 28, 2026
Net marginOF EVERY SALES DOLLAR
-6,046.2%
The share of revenue that survives every cost and becomes profit.
Gross marginPRICING POWER
86.0%
What is left of a sales dollar before overhead — the clearest read on pricing power.
Operating marginAFTER RUNNING COSTS
-6,714.8%
What survives the cost of running the whole business.
Return on equityPER $1 OF EQUITY
-46.9%
Annual return on each dollar of shareholder equity.
ROIC − WACC spreadDESTROYS VALUE
-48.2pp
Earns -40% on invested capital that costs about 8%. A positive spread means every retained dollar compounds rather than leaks.
Incremental ROIC (3y)ON NEW CAPITAL
-36.9%
The return on capital put to work over the last three years — a sharper read than the trailing average, because it prices the newest decisions.
Growth & relative strength
Trailing return by period
1 month+1.1%
3 months+145.3%
6 months+118.4%
Year to date+81.8%
1 year+145.2%
Revenue growth (YoY)FAST
+640.7%
Revenue against the same period a year ago.
Around earningsAug 3, 2026
P(beat next quarter)COHORT BASE RATE
53%
survivor-tilted universe (currently-listed names; large-cap-skewed coverage)
Beat rate · this nameBEAT 3–4 OF THE LAST 8
3 of 8
Its own record against consensus. 8 prints is a small sample, which is why the cohort rate above carries the probability.
Fell after a beatP(FELL | BEAT)
17%
A beat is not a plan: this share of them still closed lower on the day.
Rose after a missP(ROSE | MISS)
33%
The mirror of the line above, over its own denominator.
Typical earnings moveMEDIAN ABSOLUTE
±4.3%
Unsigned magnitudes from its own prints. Direction is not part of this read.
Reaction: beat vs missData unavailableThe beat-versus-miss reaction gap is not computed for this name — undetermined — needs ≥12 measured beats.
Dividends & income
Data unavailableThis company does not pay a dividend. There is no yield, payout ratio or ex-dividend date to show, and the return case rests entirely on capital gains.
Signal
Not an income position.
No dividend is declared, so nothing here contributes to total return except the price. That is a fact about the security, not a criticism of it.
Inventory ledger
Data unavailableNo inventory detail is tagged in this company's filings. The ledger needs the XBRL inventory components, which a business without physical goods does not report.
Segments & geography
Data unavailableRevenue by segment and region is not on file for this name, so product and geographic concentration are not shown.
Pattern reliability · platform-wide cohortSnapshot · Sep 28, 2026
Sideways
HorizonHigherMedianObservations
10d47%0.0%1,488,661
21d49%0.0%698,634
63d51%0.0%220,686
slope +0.02 over 40 bars
Dragonfly doji · leans bullish
HorizonHigherMedianObservations
10d35%0.0%511,532
21d39%0.0%239,326
63d44%0.0%73,988
long lower shadow, open=close near high
Double top · leans bearish
HorizonHigherMedianObservations
10d49%0.0%1,223,784
21d51%+0.1%575,197
63d52%+0.4%182,130
two peaks ≈ equal — reversal if neckline breaks
Double bottom · leans bullish
HorizonHigherMedianObservations
10d49%0.0%1,254,618
21d50%0.0%589,215
63d51%+0.3%185,963
two troughs ≈ equal — reversal if neckline breaks
Rectangle
HorizonHigherMedianObservations
10d46%0.0%223,111
21d48%0.0%104,463
63d50%0.0%32,704
horizontal range
52w breakout · leans bullish
HorizonHigherMedianObservations
10d43%0.0%196,939
21d46%0.0%92,414
63d52%+0.2%28,773
at/near 52-week high
Near support · leans bullish
HorizonHigherMedianObservations
10d51%+0.1%540,026
21d53%+0.2%252,660
63d54%+0.4%79,179
testing recent support
Rsi overbought · leans bearish
HorizonHigherMedianObservations
10d40%0.0%266,466
21d42%0.0%125,042
63d46%0.0%39,404
RSI 78 ≥ 70
03-21.2× FORWARD
Price & timing
Price $84.95, -21.2× forward earnings, RSI 93, and dealers long gamma.
↳ Plain EnglishA multiple is what the market charges for a dollar of this company's earnings, cash or revenue; the trend and the options tape say what the price is doing around it. Together they are the timing picture, not the quality one.
Momentum (RSI-14)
93OVERBOUGHT
030 oversold70 hot100
Where momentum sits on a 0–100 scale. Above 70 is overbought, below 30 oversold; the middle says the move has room either way.
The setup right now
Price · 504 sessions2024-08-29 → 2026-09-02
price50-day200-daylevel
How to read this
Up 0.00% on the session.
Follow the solid line: each point is a session close. Compare it to the 50-day average — while price stays above it the short-term trend is up, and a drop below is the first structural warning.
The dashed levels are the strikes the options chain is most committed to. They are the same numbers the gamma block states; nothing here is drawn that no section derives.
MACDBELOW SIGNAL
-0.96
The short-term trend against its own signal line. The sign is the read; the size is not a target.
Pivots (classic)R1 $85 · S1 $85
$84.95
The last settled session's range projected forward. Reference levels, not predictions — after a big gap they can sit on the wrong side of the price until the next close.
DeMark countdownUP SETUP
5 of 9
Counts consecutive closes against the prior trend. A completed 9 often marks exhaustion.
5 Nov 2026 · in 38 daysNext earningsThe next scheduled catalyst. The forward guide usually moves the tape more than the printed number. Date as the vendor last stated it on 5 Aug; companies confirm about three weeks ahead, so it can still move.
2026-09-29 · tomorrowJob Openings (JOLTS)A scheduled macro release. It moves this stock independently of anything the company does.
Setup & oddsNightly
Direction oddsnext 12m
46 / 53cohort n=3,967
A lean, not a forecast. These are the cohort's odds — comparable names over the window — not this stock's own history.
Pullback riskoverstretch read
In line1.00× segment rate · n=81,071
Historically, mid names in this tape state saw a ≥10% pullback within 63 trading days in 79% of cases (n=81,071).
Signal
The odds lean, the stretch qualifies it.
Historically, names tripping 2 validated red flags finished lower 12 months later in 53% of cases (n=3,967) — a survivor-biased floor, not a forecast.
Valuation
Net cash per shareCASH BACKING
$0.55
Cash less every borrowing, per share. It is the part of the price that is not a claim on future profits.
Multiples
Forward P/EAnalysts expect a loss over the next twelve months, so there are no earnings for the price to be a multiple of.Not meaningful
Trailing P/EThe company lost money over the trailing year, so there are no earnings for the price to be a multiple of.Not meaningful
Price / salesprice against revenue, before any of it becomes profit1,171.1×5yr median 524.0×
Price / bookprice against the accounting value of the assets9.1×
FCF yieldfree cash flow per dollar of market value-4.26%
3 of the 3 priced multiples above sit in the richer half of its band. 2 are marked not meaningful because the figure they divide into is negative — shown as absent rather than as a low, cheap-looking number. Each priced multiple is read against this stock's own history where a five-year range is on file, so the question is whether today is dear for this name rather than for the market. The multiples are computed separately from the quote above and are not re-priced as it moves, so they can lag it.
Price horizon & timing
Data unavailableThis security is delisted, so there is no live tape to compose entry, target and stop against.
Gamma mapChain · Sep 12, 2026
Signal
Long gamma — moves get absorbed.
Dealers hedge against the move, which damps volatility around the current strikes. It makes the tape quieter without saying anything about which way it goes.
Options tapeLast snapshot before the 2026-09-18 expiry · Chain · Sep 12, 2026
Max pain-11.7%
$75.00
The strike where most open options would have expired worthless on the last snapshot. That expiry has passed; the next chain read replaces it.
Put / call ratio (OI)CALL-HEAVY
0.45
69% calls
31% puts
Open interest in puts against calls. Heavy call interest often caps how far price can run before expiry.
Put / call ratio (volume)TODAY'S FLOW
5.51
Today's traded flow rather than the standing position. It moves faster and means less.
Expected move (1-week)≈ $0.01
±0.0%
What the chain prices for the week. A range the market is charging for, not a forecast.
Largest open interest · front expiry
StrikeTypeOpen interest
$85.00CALL11,748
$55.00PUT2,370
$50.00PUT1,013
$60.00PUT684
$40.00PUT396
$70.00PUT186
Large call interest above the price acts as a magnet and a ceiling; large put interest below is a floor of hedges. The biggest strike is the level the market is most committed to defending into the next expiry.
Open interest by strikeexpires 2026-09-18 (expired)CallsPutsMax pain $75.00
2
$125.00
01
$120.00
03
$100.00
034
$90.00
012k
$85.00
491
$80.00
10810
$75.00
1410
$70.00
1860
$65.00
894
$60.00
68410
$55.00
2k66
$50.00
1k45
$45.00
1560
$43.00
120
$42.00
055
$40.00
396
The shaded row is the strike nearest the price. Heavy call interest above acts as a ceiling; heavy put interest below is a floor of hedges.
↑ 52-week high$85.01+0.1%The highest print of the past year.Old highs draw profit-taking on the first attempt.
↑ Call wall$85.00+0.1%Heaviest call open interest on the front expiry.Acts as a ceiling into expiry; a close above usually needs a catalyst.
◇ Max pain$75.00-11.7%Where most open options expire worthless.Price often drifts toward it into the close of the expiry week.
↓ Put wall$55.00-35.3%Heaviest put open interest — a floor of hedges.Dealer buying tends to build as price approaches.
0413F quarterly · Form 4 dailyNET SIGNAL -7
Ownership & flow
Institutions hold 119%, short interest is 6.90% of float.
↳ Plain EnglishWho is buying and selling, and what they had to disclose. Institutions file 13F 45 days after quarter end, executives file Form 4 within two days, and Congress discloses under the STOCK Act with a 30–45 day legal lag. Every one of those is a look backwards.
Net signal
-7MODERATE · 30d
1 bull / 3 bear factors. The points sum to the net beside the label; nothing here is weighted after the fact.
The QTick signalNightly
Analyst moves90D · TIMING
-5
8 analyst downgrades in 90d
Earnings4 QUARTERS · TIMING
+1
latest EPS beat by 4%
Insider flow120D · TIMING
-1
net insider selling ($30,216,579 across 28 sells) in 120d
Quality / valueTTM · CONTEXT
-2
weak Piotroski F-score (2/9)
Signal
1 bull / 3 bear factors
Independent factors scored and netted to -7 over 30d, a moderate reading. 4 of 9 factors carried a direction; the others scored zero and do not vote. The signal describes where the data leans, not what to do about it.
Cross-category readSep 27, 2026
Signal
4 of 5 families lean down.
Descriptive only — a decorrelated read of where the evidence agrees and conflicts, not a forecast and not advice. Patterns are condition lists, not outcome predictions, and are not yet validated to the proof bar. Dispersion of 0.16 means the disagreement is real but not a split decision.
Wall Street14 covering firms
Consensus rating14 ANALYSTS
Buy
11% buy · 89% hold · 0% sell, as a share of the 14 covering firms.
Forward EPS estimateCONSENSUS
$-4.01
What the panel expects the company to earn per share.
Recent analyst moves · last 90 days
FirmTargetDirectionRank
UBS$85↑52/100
TD Cowen—↓48/100
Evercore ISI Group$85↓52/100
Jones Trading$85↓50/100
Jefferies$85↑52/100
Oppenheimer—↓56/100
Cantor Fitzgerald—↓48/100
HC Wainwright & Co.$85↑54/100
Upgrades, downgrades and target changes from covering firms. A cluster of moves in one direction matters more than any single target; the rank is the firm's own credibility score, or a dash below the scoring floor.
Who owns it13F quarterly · Form 4 daily
Institutional ownershipINSTITUTIONALLY HELD
119.2%
The share held by 13F filers. It describes last quarter's positioning, not today's — filings land up to 45 days after quarter end.
Insider ownershipOFFICERS & DIRECTORS
1.1%
The share held by the people running the company.
Short interest (float)LIGHT
6.90%
Rising — shares short changed +6.1% over 30 days. A crowded short is fuel in both directions.
Free float91% OF SHARES
95.54M
Shares actually available to trade, excluding insider and restricted holdings.
Dollar volume (ADV)95th PCTILE
$372.52M/day
At this depth, position size is not a constraint for a retail account.
Borrow feeData unavailableWe do not license securities-lending data, so the annualized cost of borrowing shares to short is not something we can show. Short interest and days-to-cover above are the closest read we can source.
Insider filings · Form 4
InsiderTradeAmountPlanTraded
Okey Stephanie · DirectorSell$503,625—01 Sep
Vivaldi Coelho Rogerio · DirectorSell$1.1M—01 Sep
Vivaldi Coelho Rogerio · DirectorSell$503,625—01 Sep
Vivaldi Coelho Rogerio · DirectorSell$545,134—01 Sep
Vivaldi Coelho Rogerio · DirectorSell$478,035—01 Sep
Okey Stephanie · DirectorSell$544,000—01 Sep
Executives must file within two business days. Sales on pre-set 10b5-1 plans are scheduled months ahead and carry little signal; tax withholding, exercises and awards are compensation mechanics, not trades; the open-market lines are the ones to read.
The story · news & sentimentRolling window
Why it moved on Sep 25, 2026NONE
0.00%
CRNX was little changed +0.00% since the last close — no notable catalyst, and the move itself was modest.
News tone · 7-day—
62 / 100
Headline polarity over the window, scored from news articles. Above 60 leans positive, below 40 negative. Colour, not a signal.
Newswire · 49 stories
WhenHeadlineSourceTone
WedCrinetics Pharmaceuticals stock exits Nasdaq after USD 85.00 deal - AD HOC NEWSAD HOC NEWSnot scored
MonCRNX Q2 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Spending Drives Results - Profitability Analysis - dars.gov.etdars.gov.etnot scored
Sep 16CRNX Q2 2026 Earnings: Loss Narrower Than Expected as Clinical-Stage Pipeline Advances - EPS Surprise History - CarePlus VietNamCarePlus VietNamnot scored
Sep 16CRNX Q2 2026 Earnings: Loss Narrower Than Expected as Clinical-Stage Pipeline Advances - Profit Inflection Point - dars.gov.etdars.gov.etnot scored
Sep 11Crinetics Pharmaceuticals, Inc. SEC Filing (Sep 11, 2026) - Stock TitanStock Titannot scored
Sep 10CRNX Q2 2026 Earnings: Narrower-Than-Expected Loss Per Share as Pre-Revenue Operations Continue - Earnings Expansion Phase - dars.gov.etdars.gov.etnot scored
Sep 4Crinetics Pharmaceuticals (CRNX) Holds Steady at $84.95 as Shares Consolidate Within Established Range - Blue Chip Entry Points - dars.gov.etdars.gov.etnot scored
Sep 3Crinetics Pharmaceuticals, Inc.(NasdaqGS:CRNX) dropped from S&P Pharmaceuticals Select Industry Index - marketscreener.commarketscreener.comnot scored
Coverage published around the move, newest first. Nothing here measures causation — only the why-it-moved card above is matched to the tape by timestamp.
CongressSTOCK Act · 30–45d lag
Signal
Net buying.
4 of 6 disclosures are buys and 2 are sales. Lawmakers disclose on a 30–45 day legal lag, so this describes what was done weeks ago, not what is being done now.
0510 graded calls
Risk & track record
a 0% worst drawdown, and 1 of 8 risk surfaces clear.
↳ Plain EnglishWhat owning it does to a portfolio, what the model votes against, and how often our own calls have been right. Every call is graded when it resolves, and the ones still open stay visible.
Max drawdown
0.0%WORST FALL
The deepest peak-to-trough fall in the measured window. Only hold a position you can watch do this.
What it does to a portfolio5-year window
What votes againstNightly
HighAnalyst moves8 analyst downgrades in 90d90d · -5
MedQuality / valueweak Piotroski F-score (2/9)TTM · -2
LowInsider flownet insider selling ($30,216,579 across 28 sells) in 120d120d · -1
Signal
3 of 9 factors vote against.
Ranked by the size of each factor's own point contribution to the net signal — these are the model's stated reasons, not a written bear case. Each one is scored from the source named beside it.
Failure modes · by company type
Data unavailableFailure modes are routed per company type, and only the bank-run and crypto-treasury rulebooks are validated so far. This name routes as growth, so there is no cohort-specific checklist to run. A generic list would read as analysis without being any.
The risk case · why not to buy8 surfaces · nightly
Avoid score6-month distress
0.6%0.1× its cohort · most-traded mega-caps
Observational 6-month large-drawdown risk ranking — not a forecast, not alpha. Historical distress rate for this most-traded mega-caps segment: 9.3%. This name reads 0.1× that base rate.
LowDistress screenThe distress model did not score this name in the latest run, so this surface is unmeasured rather than clear.Not scored
LowPosition sizeThe sizing model has not covered this name, so no defensible cap is published for it.Not scored
LowLottery-ticket behaviourNot scored for this name.Not scored
HighCash runwayAbout 1.1 quarters of cash at current burn ($114M cash against $420M a year of burn) - names in this bucket: 28.6% catastrophe rate within a year.Solvency
LowPost-earnings driftNo measured earnings reaction on file, so the drift surface is unmeasured.Not scored
LowDividend riskNot scored for this name.Not scored
LowRestatement historyFiling history is not deep enough to check for restatements.Not scored
LowCrowded shortNot in a warn state: the crowded-short model only publishes when short interest and thin liquidity coincide, and neither condition is met here.Not scored
Signal
1 of 8 surfaces clear.
8 surfaces checked, 1 clear. Each row states which surface it is and what it measured; a surface that could not be scored says so rather than counting as clear.
Who should skip it
Skip it if any of these is you
You want income
A 0.00% yield is a rounding error against cash. This is a capital-gains position.
You'd be buying into earnings
A report lands in 38 days, and the chain prices ±0.0% for the week.
Our track record10 resolved
Track recordBUILDING IN THE OPEN
19 logged
19 calls logged on this name, 10 resolved so far. Calls are logged the moment they are made, so the open ones are public before anyone knows how they turn out, and a hit-rate is not published until enough of them resolve.
Calls on CRNXTHIS NAME
19
This name's own call count. Too few have resolved to publish a rate over them, so none is shown rather than a rate over 10.
0610-K disclosed linksBIOTECHNOLOGY
The wider context
5 mapped peers, 1 connection.
↳ Plain EnglishCompanies do not trade alone. This is the peer set, the supply chain that has to deliver, and the macro variables that move the stock regardless of company news.
Rate sensitivity
+6.9% per +1ppINSUFFICIENT
This is the SECTOR prior, not a measurement of this name — the regression did not clear its own bar. The verdict beside it (neutral) comes from the prior too, so the two agree by construction rather than by evidence.
Versus peersLatest session
Peer set · 5 names
SymbolRelationshipPriceSession
VRTXPeer$526.19+0.73%
REGNPeer$788.04-1.00%
ARGXPeer$959.49-0.28%
RVMDPeer$204.97+2.56%
ALNYPeer$255.96+2.55%
The mapped peer set and how each traded in the latest session. A peer moving with this name says the move is the sector's; one moving against it says the move is this company's.
Time machineHistory from 2023-06-01
Signal
Every backward window is positive.
That is the definition of a stock that has already worked, and it says nothing about the next window. What it does tell you is what a drawdown would be measured against.
Macro driversRolling window
Next macro catalystTOMORROW
Job Openings (JOLTS)
2026-09-29. A scheduled release that moves this stock independently of anything the company does.
Events · what moves this stockSep 25, 2026
Initial jobless claimsLittle effect either way
Healthcare demand does not depend on hiring.
Typical for the Healthcare sector
On the day -0.2% · A week later +1.2% · Two weeks later +2.7% · Rose on 82 of 167 report days
Across the last 167 Initial jobless claims reports since Jun 8, 2023, CRNX moved -0.2% on average on the day and was 2.7% higher two weeks later. The S&P 500 moved 0.0% on those days.
Industrial productionLittle effect either way
Healthcare does not track the business cycle.
Typical for the Healthcare sector
On the day -0.2% · A week later -0.3% · Two weeks later +0.1% · Rose on 24 of 39 report days
Across the last 39 Industrial production reports since Jun 15, 2023, CRNX moved -0.2% on average on the day and was 0.1% higher two weeks later. The S&P 500 moved +0.1% on those days.
Producer prices (PPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.6% · A week later +0.8% · Two weeks later +0.9% · Rose on 21 of 39 report days
Across the last 39 Producer prices (PPI) reports since Jun 12, 2023, CRNX moved +0.6% on average on the day and was 0.9% higher two weeks later. The S&P 500 moved +0.3% on those days.
On the day -0.2% · A week later -0.3% · Two weeks later +0.1% · Rose on 24 of 39 report days
Across the last 39 Retail sales reports since Jun 15, 2023, CRNX moved -0.2% on average on the day and was 0.1% higher two weeks later. The S&P 500 moved +0.1% on those days.
Consumer sentiment (UMich) is due in 11 days.
Consumer sentiment (UMich)Little effect either wayLittle direct link.
Typical for the Healthcare sector
On the day +1.1% · A week later +1.7% · Two weeks later +6.7% · Rose on 18 of 38 report days
Across the last 38 Consumer sentiment (UMich) reports since Jun 26, 2023, CRNX moved +1.1% on average on the day and was 6.7% higher two weeks later. The S&P 500 moved 0.0% on those days.
Core PCE (the Fed's gauge) is due in 2 days.
Core PCE (the Fed's gauge)Little effect either wayPeople need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.3% · A week later +3.5% · Two weeks later +6.0% · Rose on 18 of 38 report days
Across the last 38 Core PCE (the Fed's gauge) reports since Jun 28, 2023, CRNX moved +0.3% on average on the day and was 6.0% higher two weeks later. The S&P 500 moved +0.2% on those days.
Core inflation (core CPI)Little effect either way
People need care regardless of prices; healthcare barely reacts to the print itself.
Typical for the Healthcare sector
On the day +0.6% · A week later +0.8% · Two weeks later +0.7% · Rose on 21 of 38 report days
Across the last 38 Core inflation (core CPI) reports since Jun 12, 2023, CRNX moved +0.6% on average on the day and was 0.7% higher two weeks later. The S&P 500 moved +0.3% on those days.
FOMC decisionLittle effect either way
Healthcare demand does not depend on rates.
Typical for the Healthcare sector
On the day +0.1% · A week later +3.5% · Two weeks later +5.8% · Rose on 20 of 38 report days
Across the last 38 FOMC decision reports since Jul 1, 2023, CRNX moved +0.1% on average on the day and was 5.8% higher two weeks later. The S&P 500 moved -0.1% on those days.
Customer momentum
Data unavailableCustomer momentum needs listed customers that disclose a revenue dependence on this company, and none is on file. The connections below are a different map: competitors and partners, most of them curated rather than filed.
Connections1 link · none confirmed
Direct connections · 1 edge
CompanyRelationSessionProvenance
ABBV · Competitorcompetitor-0.29%Rumored · manual
0 of 1 edge is named in a filing; the rest come from reporting we have not matched to one yet, and are labelled as such.
Suppliers, customers & competitors
Named competitors
ABBVCompetitorcompetitor
Glossary · every term on this page
Survival
Altman Z
Bankruptcy-risk score. Above 3.0 is the safe band.
Piotroski F
Nine pass/fail health tests; 7 or more is strong.
Beneish M
Accrual and growth pattern screen. Clear below −2.22, watch to −1.78, elevated above; a year of very fast revenue growth lifts it by construction.
Merton DTD
Standard deviations of asset value between the company and its debt.
EDF
Default frequency calibrated on what actually happened to similar names.
Price & tape
RSI-14
Momentum gauge 0–100. Above 70 is overbought, below 30 oversold.
ATR
Average true range — the size of a typical day.
VWAP
20-day volume-weighted average price — the average paid over the last month; the page shows no intraday VWAP.
Supertrend
A trend-following stop line. A close through it flips the read.
Chandelier
A trailing stop set a few average ranges below the recent high.
Options & flow
Gamma / GEX
Dealer hedging pressure. Negative gamma amplifies moves both ways.
Call / put wall
The strikes with the heaviest open interest; they act as ceiling and floor.
Max pain
The strike where most options expire worthless.
13F · Form 4
Institutional filings, 45 days after quarter end. Insider trades, within two days.
Scoring
Composite signal
Independent factors scored and netted into one number.
Hit-rate
Share of past calls that resolved in the direction stated.
Brier score
Calibration measure. Lower means stated probabilities track reality.
HHI
Concentration 0–10,000. Above 2,500 means one segment carries the company.
EVT
Fits the tail rather than assuming a bell curve, so bad days are not understated.